Citation: G. Riethmuller et Ca. Klein, Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients, SEM CANC B, 11(4), 2001, pp. 307-311
Authors:
Raum, T
Gruber, R
Riethmuller, G
Kufer, P
Citation: T. Raum et al., Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigens, CANCER IMMU, 50(3), 2001, pp. 141-150
Authors:
Blazar, M
Briaire-De Bruijn, IH
Rees-Bakker, HAM
Prins, FA
Helfrich, W
de Leij, L
Riethmuller, G
Alberti, S
Warnaar, SO
Fleuren, GJ
Litvinov, SV
Citation: M. Blazar et al., Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions, MOL CELL B, 21(7), 2001, pp. 2570-2580
Authors:
Weckermann, D
Muller, P
Wawroschek, F
Harzmann, R
Riethmuller, G
Schlimok, G
Citation: D. Weckermann et al., Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: Detection and prognostic value, J UROL, 166(2), 2001, pp. 699-704
Authors:
Maletz, K
Kufer, P
Mack, M
Raum, T
Pantel, K
Riethmuller, G
Gruber, R
Citation: K. Maletz et al., Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity, INT J CANC, 93(3), 2001, pp. 409-416
Authors:
Hempel, D
Muller, P
Oruzio, D
Behr, W
Brockmeyer, C
Wochner, M
Ehnle, S
Riethmuller, G
Schlimok, G
Citation: D. Hempel et al., Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells, CYTOTHERAPY, 2(4), 2000, pp. 287-295
Authors:
Zippelius, A
Lutterbuse, R
Riethmuller, G
Pantel, K
Citation: A. Zippelius et al., Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells, CLIN CANC R, 6(7), 2000, pp. 2741-2750
Authors:
Braun, S
Pantel, K
Muller, P
Janni, W
Hepp, F
Kentenich, CRM
Gastroph, S
Wischnik, A
Dimpfl, T
Kindermann, G
Riethmuller, G
Schlimok, G
Citation: S. Braun et al., Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer., N ENG J MED, 342(8), 2000, pp. 525-533
Authors:
Gruber, R
van Haarlem, LJM
Warnaar, SO
Holz, E
Riethmuller, G
Citation: R. Gruber et al., The human antimouse immunoglobulin response and the anti-idiotypic networkhave no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A, CANCER RES, 60(7), 2000, pp. 1921-1926
Authors:
Loffler, A
Kufer, P
Lutterbuse, R
Zettl, F
Daniel, PT
Schwenkenbecher, JM
Riethmuller, G
Dorken, B
Bargou, RC
Citation: A. Loffler et al., A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes, BLOOD, 95(6), 2000, pp. 2098-2103
Authors:
Braun, S
Hepp, F
Kentenich, CRM
Janni, W
Pantel, K
Riethmuller, G
Willgeroth, F
Sommer, HL
Citation: S. Braun et al., Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow, CLIN CANC R, 5(12), 1999, pp. 3999-4004
Authors:
Weckermann, D
Muller, P
Wawroschek, F
Krawczak, G
Riethmuller, G
Schlimok, G
Citation: D. Weckermann et al., Micrometastases of bone marrow in localized prostate cancer: Correlation with established risk factors, J CL ONCOL, 17(11), 1999, pp. 3438-3443
Authors:
Klein, CA
Schmidt-Kittler, O
Schardt, JA
Pantel, K
Speicher, MR
Riethmuller, G
Citation: Ca. Klein et al., Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells, P NAS US, 96(8), 1999, pp. 4494-4499
Authors:
Schakel, K
Mayer, E
Federle, C
Schmitz, M
Riethmuller, G
Rieber, EP
Citation: K. Schakel et al., A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes, EUR J IMMUN, 28(12), 1998, pp. 4084-4093